Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1986 1
1998 1
1999 1
2002 1
2004 1
2007 1
2008 1
2010 2
2012 1
2013 2
2015 2
2016 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Review of lymphoma in the duodenum: An update of diagnosis and management.
Iwamuro M, Tanaka T, Okada H. Iwamuro M, et al. World J Gastroenterol. 2023 Mar 28;29(12):1852-1862. doi: 10.3748/wjg.v29.i12.1852. World J Gastroenterol. 2023. PMID: 37032723 Free PMC article. Review.
The presentation, subtype, and macroscopic images of lymphoma vary depending on the site of the tumor within the gastrointestinal tract. ...The most predominant primary duodenal lymphoma was follicular lymphoma. In this review, we provide an update of the dia …
The presentation, subtype, and macroscopic images of lymphoma vary depending on the site of the tumor within the gastrointestinal tra …
Idelalisib for treatment of B-cell malignancies.
Do B, Mace M, Rexwinkle A. Do B, et al. Am J Health Syst Pharm. 2016 Apr 15;73(8):547-55. doi: 10.2146/ajhp150281. Epub 2016 Mar 1. Am J Health Syst Pharm. 2016. PMID: 26933132 Review.
PURPOSE: The pharmacology, pharmacokinetics, clinical efficacy, safety and tolerability, dosing and administration, and place in therapy of idelalisib, a targeted therapy for certain types of non-Hodgkin's lymphoma (NHL), are reviewed. ...Ongoing clinical stu …
PURPOSE: The pharmacology, pharmacokinetics, clinical efficacy, safety and tolerability, dosing and administration, and place in therapy …
Gastrointestinal lymphoma: recent advances in diagnosis and treatment.
Nakamura S, Matsumoto T. Nakamura S, et al. Digestion. 2013;87(3):182-8. doi: 10.1159/000350051. Epub 2013 Apr 27. Digestion. 2013. PMID: 23635497 Review.
The recent trends in the diagnosis and management of gastrointestinal lymphoma are reviewed. Primary gastrointestinal lymphoma accounts for 30-40% of all extranodal lymphomas, while it comprises only 1-8% of all gastrointestinal malignancies. The most common histolo …
The recent trends in the diagnosis and management of gastrointestinal lymphoma are reviewed. Primary gastrointestinal lymphoma …
Management of the marginal zone lymphomas.
Vannata B, Stathis A, Zucca E. Vannata B, et al. Cancer Treat Res. 2015;165:227-49. doi: 10.1007/978-3-319-13150-4_9. Cancer Treat Res. 2015. PMID: 25655612 Review.
In the context of a persistent antigenic stimulation, successive genetic abnormalities can progressively hit a B-cell clone among the reactive B-cells of the chronic inflammatory tissue and give rise to a MALT lymphoma. ...In non-gastric MALT lymphoma …
In the context of a persistent antigenic stimulation, successive genetic abnormalities can progressively hit a B-cell clone am …
Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract.
Aleman BM, Haas RL, van der Maazen RW. Aleman BM, et al. Best Pract Res Clin Gastroenterol. 2010 Feb;24(1):27-34. doi: 10.1016/j.bpg.2009.12.002. Best Pract Res Clin Gastroenterol. 2010. PMID: 20206106 Review.
The most common histological subtypes are extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) and diffuse large B-cell lymphoma (DLBCL). The role of radiotherapy is most definite in early stage gastric …
The most common histological subtypes are extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid ti …
The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas.
Foster LH, Portell CA. Foster LH, et al. Curr Treat Options Oncol. 2015 Jun;16(6):28. doi: 10.1007/s11864-015-0344-6. Curr Treat Options Oncol. 2015. PMID: 25975444 Review.
There is strong evidence to corroborate the association with Helicobacter pylori (Hp) to gastric extranodal marginal zone lymphoma (ENMZL) and hepatitis C virus (HCV) to splenic/nodal marginal zone lymphoma. ...Other infectious associations to indolent lymphomas hav …
There is strong evidence to corroborate the association with Helicobacter pylori (Hp) to gastric extranodal marginal zone lymphoma (E …
Clinical outcome of non-surgical treatment for primary small intestinal lymphoma diagnosed with double-balloon endoscopy.
Kobayashi H, Nagai T, Omine K, Sato K, Ozaki K, Suzuki T, Mori M, Muroi K, Yano T, Yamamoto H, Ozawa K. Kobayashi H, et al. Leuk Lymphoma. 2013 Apr;54(4):731-6. doi: 10.3109/10428194.2012.725850. Epub 2012 Sep 28. Leuk Lymphoma. 2013. PMID: 22946663
Primary small intestinal lymphoma (PSIL) is often treated with surgical resection, and therefore response to non-surgical treatment is rarely known. We retrospectively analyzed the clinicopathological features of 19 patients with PSIL, who had been diagnosed …
Primary small intestinal lymphoma (PSIL) is often treated with surgical resection, and therefore response to non-surgic …
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma: a multivariate analysis of 76 cases.
Sanchez-Bueno F, Garcia-Marcilla JA, Alonso JD, Acosta J, Carrasco L, Piñero A, Parrilla P. Sanchez-Bueno F, et al. Eur J Surg. 1998 May;164(5):385-92. doi: 10.1080/110241598750004427. Eur J Surg. 1998. PMID: 9667473
OBJECTIVE: To present our experience with the treatment of primary gastrointestinal (GI) non-Hodgkin's lymphoma, evaluate prognostic factors, and give our recommendations for treatment. ...INTERVENTIONS: 52 patients had radical resections, 19 palliative resections, and 5 b …
OBJECTIVE: To present our experience with the treatment of primary gastrointestinal (GI) non-Hodgkin's lymphoma, evaluate prognostic …
Clinical Characteristics and Treatment Outcome of Gastrointestinal Non-Hodgkin's Lymphoma.
Praveen S, Ho CC, Fadilah S, Sagap I. Praveen S, et al. Med J Malaysia. 2010 Jun;65(2):98-100. Med J Malaysia. 2010. PMID: 23756789 Free article.
The majority had advanced diseases (stage III and IV) with equal distribution involving the stomach, small and large intestines. The most common histological variant was diffuse large B cell lymphoma (66%). Most (83%) patients with intestinal …
The majority had advanced diseases (stage III and IV) with equal distribution involving the stomach, small and large intestines. The …
17 results